Cagri 3R Blend (20mg)

Cagri 3R Blend (20mg) refers to a research chemical formulation combining Cagrilintide (an amylin analog) and Retatrutide (a triple agonist targeting GLP-1, GIP, and glucagon receptors). These substances are often marketed by vendors like AMC Essentials as unregulated powders strictly for laboratory research—they are not approved medical treatments for human consumption.